Pasithea Therapeutics Corp.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation
DE
Business Address
1111 LINCOLN ROAD, SUITE 500, MIAMI BEACH, FL, 33139
Mailing Address
1111 LINCOLN ROAD, SUITE 500, MIAMI BEACH, FL, 33139
Phone
(702) 514-4174
Fiscal Year End
1231
EIN
851591963
Financial Overview
FY2025
$60.24M
Total Assets
$5.02M
Total Liabilities
$55.22M
Stockholders' Equity
$55.16M
Cash & Equivalents
$-2.91
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | March 30, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 27, 2026 | View on SEC |
| 8-K Current report of material events | February 20, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 17, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 17, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 17, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 12, 2026 | View on SEC |
| 8-K Current report of material events | January 28, 2026 | View on SEC |
| DEF 14A Definitive proxy statement | December 29, 2025 | View on SEC |
| 8-K Current report of material events | December 15, 2025 | View on SEC |
Annual Reports
10-K
March 30, 2026
- PAS-004 shows promising safety profile with no serious side effects in early trials.
- Strategic pivot to focus exclusively on PAS-004 to optimize cash runway.
Material Events
8-K
Financial Distress
February 20, 2026
High Impact
- Pasithea Therapeutics Corp. received a Nasdaq notice for failing to meet the minimum $1.00 bid price requirement.
- The company has 180 calendar days (until August 19, 2026) to regain compliance by maintaining a $1.00 stock price for 10 consecutive business days.
8-K
Legal Issue
December 15, 2025
High Impact
- Pasithea Therapeutics Corp. successfully resolved a major issue with the Nasdaq stock exchange.
- The company has officially regained compliance with Nasdaq's minimum bid price rule ($1.00 per share).
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.